Detalles de la búsqueda
1.
Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States.
J Urol
; 206(6): 1420-1429, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34293915
2.
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
Circulation
; 134(24): 1918-1930, 2016 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27881559
3.
Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data.
Curr Med Res Opin
; 37(4): 609-622, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476184
4.
Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity.
J Clin Pharmacol
; 59(3): 427-436, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30452776
5.
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial.
J Am Heart Assoc
; 4(8): e002171, 2015 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26307570
6.
Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study.
Clin Ther
; 32(12): 2074-87, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21118743
7.
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
Cancer Chemother Pharmacol
; 66(2): 345-56, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19911123
Resultados
1 -
7
de 7
1
Próxima >
>>